ICCC
Immucell·NASDAQ
--
--(--)
--
--(--)
ICCC fundamentals
Immucell (ICCC) Revenue Breakdown: Q3 2025 Business & Regional Performance
Immucell (ICCC) reported total revenue of 5.51M USD in Q3 2025, with its core business segment Scours contributing 98.88%. Regionally, United States remained the largest market, accounting for 96.91% of total revenue. Explore Immucell's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Immucell (ICCC) reported total revenue of 5.51M USD in Q3 2025, with its core business segment Scours contributing 98.88%. Regionally, United States remained the largest market, accounting for 96.91% of total revenue. Explore Immucell's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What factors drove the changes in Immucell's revenue and profit?Did Immucell beat or miss consensus estimates last quarter?What were the key takeaways from Immucell's earnings call?What does Immucell do and what are its main business segments?What is Immucell's latest dividend and current dividend yield?What is Immucell's gross profit margin?What is the market's earnings forecast for Immucell next quarter?What guidance did Immucell's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
